The EUPHORIA team enjoyed a very productive meeting in Besancon, France last week. The meeting ran over 2 days (23 and 24 January 2020) and all the partners were represented.
Researchers presented updates on all workstreams. IMASONIC and iThera outlined the significant progress made on improving the probe and transducer for the MSOT device. Final testing of the prototypes will be completed shortly and the choice of the transducer for use in the trial will be confirmed. Testing to date shows significant improvements. Software tasks in WP3 (led by Rayfos) are also well advanced.
Now that the EUPHORIA study protocol is near-final, work in WP4 by iThera and UK Erlangen is focused on preparations for the trial and obtaining ethical approval. Plans were discussed for a study workshop with the Advisory Board in February.
Preliminary work on certification of the device has already commenced in WP5 and dissemination and communication activities continue, with the new project video due for release shortly.
By the end of the meeting, the partners had agreed to a plan for the busy months ahead. Many thanks to our hosts in IMASONIC for a very fruitful and enjoyable event!
Learn more about EUPHORIA at www.euphoria2020.eu
Follow the project on Twitter @EUPHORIAH2020 and on Facebook @EUPHORIAH2020
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 830965. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.